UroGen Pharma Ltd. (URGN) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-20 | 8-K | Other Events | SEC |
| 2026-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-23 | 8-K | Item 3.03, Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-06-02 | 8-K | Other Events | SEC |
| 2026-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-02 | 8-K | Material Agreement, Direct Financial Obligation | SEC |
| 2026-03-02 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-27 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-03 | 8-K | Officer / Director Changes | SEC |
| 2025-06-13 | 8-K | Other Events | SEC |
| 2025-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-20 | 8-K | Material Agreement, Unregistered Sales | SEC |
| 2025-01-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-09 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-09-24 | 8-K | Direct Financial Obligation | SEC |
| 2024-09-13 | 8-K | Officer / Director Changes | SEC |
| 2024-08-15 | 8-K | Other Events | SEC |
| 2024-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-08 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-06-18 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-13 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-01 | 8-K | Reg FD Disclosure | SEC |
| 2024-02-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-17 | 8-K | Material Agreement, Other Events | SEC |
| 2024-01-02 | 8-K | Material Agreement | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.